Passage Bio's PBKR03 Receives Orphan Drug and Rare Pediatric Disease Designations from FDA for Treatment of Krabbe DiseaseGlobeNewsWire • 10/28/20
Passage Bio's PBGM01 Receives Orphan Drug Designation from EMA for Treatment of GM1 GangliosidosisGlobeNewsWire • 10/26/20